|
Report Date : |
22.02.2012 |
IDENTIFICATION DETAILS
|
Name : |
AL ANDALOUS MEDICAL COMPANY |
|
|
|
|
Registered Office : |
El Zeny Tower, 6th Floor 25 Misr Helwan Agricultural Road
Maadi Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Year of Establishment : |
2001 |
|
|
|
|
Com. Reg. No.: |
31143, Cairo |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacturer of cosmetics and pharmaceutical products |
|
|
|
|
No. of Employees : |
45 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 150,000 |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Egypt |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : AL ANDALOUS MEDICAL COMPANY
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 2001
Commercial Registration Number : 31143, Cairo
Tax Card Number : 763-612-611
Issued Capital : £E 1,000,000
Paid up Capital : £E 1,000,000
Total Workforce : 45
Activities : Manufacturer of cosmetics and pharmaceutical products
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
Recommended Credit Limit : US$ 150,000
Person Interviewed : Hazem Mahmoud, Financial Manager
AL ANDALOUS MEDICAL COMPANY
Building : El Zeny
Tower, 6th Floor
Street : 25 Misr
Helwan Agricultural Road
Area : Maadi
Town : Cairo
Country : Egypt
Telephone : (20-2) 23580826
/ 23580832 / 23580752
Facsimile : (20-2)
23580507
Mobile : (20-12)
9999355 / 9999356
Email : hzmamin@yahoo.com
/ nhany@alandalous.org
/ info@alandalous.org
Subject operates from a medium sized suite of offices that are rented and
located in the Central Business Area of Cairo.
Name Position
· Dr Mohamed Ahmed
Ibrahim Chairman
· Dr Rouf Fayeq General
Manager & Scientific Manager
· Dr Sawfat
Abdulmoniem Plant
Manager
· Hazem Mahmoud Financial
Manager
Date of
Establishment : 2001
Legal Form : Egyptian Joint
Stock Company
Commercial Reg.
No. : 31143, Cairo
Tax Card No. :
763-612-611
Issued Capital : £E 1,000,000
Paid up Capital : £E 1,000,000
· Dr Mohamed Ahmed
Ibrahim
· Members of Dr
Mohamed Ahmed Ibrahim’s family
· Al Andalous
Pharmaceutical Company
El Zeny Tower, 6th Floor
25 Misr Helwan Agricultural Road
Maadi
Cairo
Activities: Engaged in the manufacture of cosmetics and pharmaceutical products.
Import Countries: Europe and the Far East
Operating Trend: Steady
Subject has a workforce of 45 employees.
Financial highlights provided by local sources are given below:
Currency: Egyptian Pounds (£E)
Year
Ending 31/12/09: Year
Ending 31/12/10:
Total Sales £E
14,370,000 £E
15,100,000
Local sources consider subject’s financial condition to be Fair.
The above financial figures are based on estimations by our local
sources.
·
Commercial International Bank (CIB)
Nile Tower Building
21-23 Giza Street
PO Box: 2430
Cairo
Tel: (20-2) 25703043
Fax: (20-2) 25703172 / 25072691
No complaints regarding subject’s payments have been reported.
During the course of this investigation nothing detrimental was
uncovered regarding subject’s operating history or the manner in which payments
are fulfilled. As such the company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.08 |
|
|
1 |
Rs.77.80 |
|
Euro |
1 |
Rs.65.17 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.